Ana Echarri

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

María Chaparro, Ana Garre, Andrea Núñez Ortiz et al. · Journal of Clinical Medicine · 2021 · 92 citations · Full text

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

Inflammation, Anti-inflammatory, Immunology +7

Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn’s Disease Recurrence. A GETECCU Randomised Trial

Antonio López–Sanromán, Isabel Vera‐Mendoza, Eugeni Domènech et al. · Journal of Crohn s and Colitis · 2017 · 80 citations · Full text

Fecal Calprotectin in Ileal Crohnʼs Disease

Elena Cerrillo, Belén Beltrán, Salvador Pous et al. · Inflammatory Bowel Diseases · 2015 · 63 citations · Full text

A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.

William Zabala‐Fernández, Manuel Barreiro‐de Acosta, Ana Echarri et al. · PubMed · 2011 · 48 citations